Diversified Tracked since Q3 FY26 - Q3 FY26

Gufic Biosciences Limited

Compare with...

GUFICBIOSCIENCES

Latest quarter Q3 FY26

Revenue ₹231 Cr

Management credibility Building

Promise tracking available after 2+ quarters of coverage.

View all executive profiles for Gufic Biosciences Limited

Latest signal neutral medium

Gufic Biosciences reported Q3 FY26 revenue of ₹231.1 crore, flat sequentially, as a conscious ₹14-16 crore revenue hi...

Quarterly Earnings Timeline

Financial verification status, call summary, sentiment, and management-delivery signals by quarter.

1 quarter

Q3 FY26 10 Feb 2026

Revenue ₹231 Cr

Gufic Biosciences reported Q3 FY26 revenue of ₹231.1 crore, flat sequentially, as a conscious ₹14-16 crore revenue hit from restructuring critical care and SPARSH dist...

neutral medium

Scorecard starts after historical backfill Read full analysis →